A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism
Clinical trial NCT04701203 · COMPLETED
Trial details
- NCT number
- NCT04701203
- Sponsor
- Ascendis Pharma Bone Diseases A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2022-01-12
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.